Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

ADC and Radiopharmaceuticals Pharma and Biotech Partnering Summit

Evvnt Promotion / evvnt
Archivio
-
09.09.2024 - 10.09.2024  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Temi della conferenza
Major moves in the pharma and biotech partnering are reshaping the landscape. With AbbVie's acquisition of ImmunoGen leading the charge in 2023, and Merck's licensing deal with Daiichi reaching unprecedented heights across three ADC programs, the market frenzy surrounding ADCs has never been hotter.

Even Eli Lilly's acquisition of Mablink, despite lacking clinical programs, underscores the feverish pace of activity in the field, breaking traditional pharma partnering trends.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2481194-3?pid=4832

Speakers: Adrianne Wong, Director, Oncology Search and Evaluation, Global Business Development, Daiichi Sankyo, Albert Hsia, Executive Director, Business Development, Merck, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2481194-2?pid=4832
Ms. Karina Bikerniece
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Two Day Attendance and Access to Partnering Portal - Biotech, Pharma and Investors: USD 2999.00, Two Day Attendance and Access to Partnering Portal - Academics: USD 2399.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für WiennewTreeCharité International AcademyHelix - Forschung & Beratung WienAMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.